Demand for Obesity Drugs Has Insurers Paying Close Attention
Wall Street Journal
Strong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results.
https://www.wsj.com/articles/demand-for-obesity-drugs-has-insurers-paying-close-attention-7330d093